• News
  • SAN DIEGO
  • Medical

Sanitas gets FDA approval for mobile patient monitor

Sanitas Inc., a San Diego company developing mobile and Web solutions for outpatients with chronic conditions, has received approval from the U.S. Food and Drug Administration on a 510(K) class II medical device for Wellaho, its proprietary mobile and web platform.

Wellaho is a physician-directed, Web-based and mobile platform that allows providers to supervise and monitor patients between office visits in a secure, HIPAA compliant environment. It enables patients to access their medical information, monitor their condition, stream relevant educational materials and connect securely to their doctors and health care team.

Wellaho's personalized outpatient management system is currently deployed in a number of clinical studies at UC San Diego Health Services.

RELATED ARTICLES:

Bill Walton promotes NuVasive's spinal surgery around country

Scripps taking over San Diego Hospice & Palliative

Santarus launches colitis drug

Leave Your Comment

Comments are moderated by SDDT, in accordance with the SDDT Comment Policy, and may not appear on this commentary until they have been reviewed and deemed appropriate for posting. Also, due to the volume of comments we receive, not all comments will be posted.

SDDT Comment Policy: SDDT encourages you to add a comment to this discussion. You may not post any unlawful, threatening, defamatory, obscene, pornographic or other material that would violate the law. All comments should be relevant to the topic and remain respectful of other authors and commenters. You are solely responsible for your own comments, the consequences of posting those comments, and the consequences of any reliance by you on the comments of others. By submitting your comment, you hereby give SDDT the right, but not the obligation, to post, air, edit, exhibit, telecast, cablecast, webcast, re-use, publish, reproduce, use, license, print, distribute or otherwise use your comment(s) and accompanying personal identifying and other information you provide via all forms of media now known or hereafter devised, worldwide, in perpetuity. SDDT Privacy Statement.

User Response
0 UserComments

Leave Your Comment

Comments are moderated by SDDT, in accordance with the SDDT Comment Policy, and may not appear on this commentary until they have been reviewed and deemed appropriate for posting. Also, due to the volume of comments we receive, not all comments will be posted.

SDDT Comment Policy: SDDT encourages you to add a comment to this discussion. You may not post any unlawful, threatening, defamatory, obscene, pornographic or other material that would violate the law. All comments should be relevant to the topic and remain respectful of other authors and commenters. You are solely responsible for your own comments, the consequences of posting those comments, and the consequences of any reliance by you on the comments of others. By submitting your comment, you hereby give SDDT the right, but not the obligation, to post, air, edit, exhibit, telecast, cablecast, webcast, re-use, publish, reproduce, use, license, print, distribute or otherwise use your comment(s) and accompanying personal identifying and other information you provide via all forms of media now known or hereafter devised, worldwide, in perpetuity. SDDT Privacy Statement.